PHARMACEUTICAL INGREDIENTS FUNDAMENTALS EXPLAINED

“The existing situation has uncovered some structural weaknesses within the EU’s medicines offer chain plus a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She proposed that supply chain problems be dealt with within an EU pharmaceutical system predicted being introduced by